Pathway-Focused Gene Expression Panels Validated for Real-time PCR
News Apr 08, 2010
Fluidigm Corporation and SABiosciences have announced that they have teamed up to create over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System for Genetic Analysis. These kits are named the RT² Profiler™ PCR Arrays for the Fluidigm BioMark system.
These gene expression assays are specifically designed for the workflow of Fluidigm's integrated fluidic circuits (IFCs) and the BioMark system. Each reagent kit includes pre-aliquoted reagents and primers needed for synthesizing first-strand cDNA ready for preamplification and pathway-focused analysis. PCR Arrays contain enough reagent to run five 96.96 Dynamic Array chips (customized panels are also available). PCR arrays come in a 96-well format making either 96.96 or 48.48 Dynamic Array™ chip set up fast and simple.
"SABiosciences solutions focusing on the analysis of pathways with real time assay panel kits are an excellent fit to our products. The kits include 96 cataloged gene expression assays, targeting genes in signal transduction, biological process, and disease-related pathways. The kits can provide a great solution for customers looking to lower start up costs, or that need pre-validated pathways for a new project," said Mike Lee, Fluidigm's Senior Director of Marketing.
"SABiosciences offers real-time PCR Arrays that are the most reliable and sensitive gene expression profiling technology for analyzing a focused panel of genes and now gain the additional benefits of Fluidigm's genetic analysis technology," said Shankar Sellappan, Ph.D., SABiosciences PCR Array Product Manager.
Genetic Variations in the Lungs Identify COPD RiskNews
Developmental genetic variations in the anatomy of the lung could indicate people at risk of COPD later in life, a study suggests.READ MORE
Proteasome Blocker Brings Glaucoma Gene Therapy CloserNews
An enhanced gene therapy technique that pairs a viral vector with a proteasome blockade has doubled the therapy's efficiency.READ MORE
New Class of Decoy Molecules that Prevent the Onset of PainNews
Researcher report a new method of reducing pain-associated behaviors with RNA-based medicine, creating a new class of decoy molecules that prevent the onset of pain.READ MORE